Back
Fulgent Genetics 10K Form
Sell
40
FLGT
Fulgent Genetics
Last Price:
20.11
Seasonality Move:
6.78%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive FLGT News And Ratings
See the #1 stock for the next 7 days that we like better than FLGT
FLGT Financial Statistics
Sales & Book Value
| Annual Sales: | $289.21M |
|---|---|
| Cash Flow: | $11.83M |
| Price / Cash Flow: | 124.82 |
| Annual Sales: | $38.31 |
| Price / Book: | 0.53 |
Profitability
| EPS (TTM): | -5.64000 |
|---|---|
| Net Income (TTM): | $-167.83M |
| Gross Margin: | $104.46M |
| Return on Equity: | -13.54% |
| Return on Assets: | -12.5% |
Fulgent Genetics Earnings Forecast
Key Fulgent Genetics Financial Ratios
- The Gross Profit Margin over the past 10 years for FLGT is 36.12%.
- The Selling, General & Administrative Expenses for FLGT have been equal to 45.11% of Gross Profit Margin.
- The Research & Development expenses have been 14.33% of Revenue.
- The Net Earning history of FLGT is -58.03% of Total Revenues.
- Per Share Earnings over the last 10 years have been positive in 4 years.
Fulgent Genetics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Providers & Services |
| Sector: | Health Care |
| Current Symbol: | FLGT |
| CUSIP: | 359664 |
| Website: | fulgentgenetics.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 6.96 |
| Quick Ratio: | 6.6 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
FLGT Technical Analysis vs Fundamental Analysis
Sell
40
Fulgent Genetics (FLGT)
is a Sell
Is Fulgent Genetics a Buy or a Sell?
-
Fulgent Genetics stock is rated a Sell
The current Fulgent Genetics [FLGT] share price is $20.13. The Score for FLGT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.